Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,462 total articles
Lumentum (LITE) sits at the intersection of optical components and high‑power lasers that modern AI data centers will need as they shift from copper and discrete optics to co‑packaged and near‑packaged photonics. Fundamentals show rapid demand acceleration and improving technical momentum, but the multiple is rich. This trade idea targets an action…
Flex's $4.4B purchase of EPC Power and the planned Q1 2027 spin-off of its Cloud and Power Infrastructure (CPI) business materially improve growth and margin optionality. With CPI revenue growth accelerating, EPC Power adding a near-term $800M revenue stream and EBITDA margins that can approach 30%, and a corporate valuation that still leaves room …
AMC has moved from meme momentum to a setup where revenue recovery, premium-seat expansion and improving EBITDA are supporting price action. With a $2.67B market cap, EV/EBITDA near 10 and technical momentum intact, the mid-term trade is to buy AMC with a clear stop and a realistic profit target tied to multiple expansion and box-office upside.
Star Bulk (SBLK) checks multiple boxes as we head into the Q3 print: meaningful insider buying, a juicy dividend that equates to roughly 12.2% at today's price, a reasonably cheap valuation (PE ~11.4, PB ~1.32) and exposure to a dry-bulk market with upside if freight rates remain firm. We reiterate Buy with a clear entry, stop and target and a mid-…
NICE shares have traded lower after messy growth prints earlier in the year, but recent technicals, a defensible cash-generating business and a reasonable $6.6B market cap make a mid-term long trade attractive. Entry at current levels, a tactical stop under $101 and a target near $125 balances reward and risk for a 45-trading-day campaign.
Nvidia's fundamentals and continued enterprise AI adoption support a base-case long. Market-cap scale, high free cash flow and healthy return metrics back a measured buy-on-dip trade. This is a disciplined trade idea: enter near current levels, place a protective stop below structural support, and target meaningful upside driven by data-center dema…
Masco's limited exposure to new-home construction and strong cash generation give it defensive characteristics that matter while housing remains soft. With a TTM EPS near $4.49, FCF of $1.13B and management accelerating a $300M buyback, the risk/reward looks attractive from current levels. This trade idea lays out an entry at $67.84, a $78 upside t…
Cardinal Health (CAH) looks buyable around $223.81. The business generates strong free cash flow ($4.525B) and sits on a $51.8B market cap with operational levers to defend margins. Valuation is not dirt-cheap on a P/E of ~30, but P/S of 0.2 and EV/EBITDA ~14.5 leave room if management executes on specialty and efficiency initiatives. Trade plan pr…
Liquidia plunged intraday on heavy volume, opening a tactical long opportunity. Yutrepia is already driving multi-hundred-million dollar sales and four consecutive profitable quarters; the legal fight with United Therapeutics is a material risk but not a guaranteed existential threat. This trade targets a rebound toward normalizing valuations while…
Lexaria (LEXX) is a micro-cap play with cash on the balance sheet greater than its market cap, an undervalued drug-delivery IP portfolio, and recent technical oversold conditions. This is a high-risk, event-driven trade: the plan is to enter at $3.06, use a tight stop near the 52-week low, and hold for major licensing or corporate-development catal…
Microsoft's Copilot has moved from experimental feature to a coherent go-to-market play across Office, Dynamics, and Azure. The company now has product bundles, enterprise sales motions, and pricing experiments that make meaningful ARR upside credible. This trade aims to buy that narrative, targeting a re-rating over the next 180 trading days while…
Hingham Institution for Savings (HIFS) has pulled back into the mid $200s after a rate‑driven earnings scare. With a market cap near $620M, a P/E under 10 and a P/B around 1.26, this is a disciplined mid‑term long for investors who want bank exposure with a compact share base and an above‑average track record of returning capital.
Constellation Energy (CEG) just pulled back into the mid-$200s after a run from its 2022 spin. With the largest U.S. nuclear fleet (22 GW), improving cash flow and a clear route to data-center and corporate contracts, this sell-off offers a tactical long entry. We lay out an entry at $253.55, a $330 target and a $230 stop, with catalysts and risk c…
TotalEnergies (TTE) is an integrated energy major trading at a modest multiple with a 4.4% yield, diversified cash generators across oil, gas, LNG and power, and technicals that look repairable from current levels. This is an actionable long trade targeting recovery toward last year's highs while capturing a high yield and implied stability from lo…
Woori Financial Group (WF) looks attractive after a recent pullback. The ADS is trading at $75.03 with a market cap near $18.6B, a P/E of 9.2 and a P/B under 0.85. With a 3.4% dividend yield, modest short interest and a 52-week range of $48.83-$84.71, the setup favours a tactical long over the next 45 trading days provided macro and domestic bankin…
Universal Corporation (UVV) looks oversold after a pullback to its 52-week low. The stock trades at roughly 0.75x book, yields ~7.9%, and generates meaningful free cash flow relative to its market cap. For disciplined traders comfortable owning a cyclical, tobacco-adjacent business, this is a mid-term mean-reversion trade with income and valuation …
Workday has accelerating AI adoption (agentic AI ARR near $600M) and expanding operating margins. If management follows through with headcount reductions or other cost discipline, those margin gains can compound free cash flow and justify upside from the current $190 area. This trade targets a mid-term move to $225 while protecting capital with a $…
<p>Dyne shares have sold off sharply after a rival's DM1 data created fear that the whole exon-skipping / oligonucleotide cohort will be re-rated. That knee-jerk reaction opens a tactical, high-conviction long with defined risk controls for traders willing to accept binary development risk. The trade rests on Dyne's program differentiation, upcomin…
FICO plunged after an FHFA-driven change to mortgage pricing and faces accelerating competition from AI lenders that bypass traditional scores. The shares are already down to $592.90 from a $1,998 high last year. Fundamentals (strong free cash flow but a higher EV) and heavy recent short activity support a mid-term short opportunity. Trade sized ca…
uniQure plunged after a disappointing 48-month update for AMT-130, creating a volatile opportunity. The company still commands a $1.7B market cap, meaningful cash and an expanded June equity raise. This trade is a speculative long with a clear entry, stop and target for investors willing to tolerate clinical and legal risk over a multi-month horizo…
Hims & Hers (HIMS) looks actionable after a steep post-FTC reset. U.S. revenue reacceleration, positive cash flow and a market cap near $7.08B create a favorable entry at current levels. We upgrade to a tactical long with a $40 target and a $25 stop, horizon 180 trading days.
Precigen looks positioned for a re-rating if a Platform Technology designation from the FDA accelerates licensing, partnerships and institutional interest. The stock has run to $8.57 on heavy volume and a stretched RSI, but underlying float, short interest and a still-substantial enterprise value give room for a momentum-driven squeeze. Trade plan …
Anthropic’s reported $110 billion commitment to cloud and chips shifts the calculus for AI infrastructure spending. That benefits Amazon Web Services (AWS) directly and supports a long directional trade in Amazon, but the stock’s valuation and negative free cash flow require precise risk management. I reiterate a constructive stance with a long tra…
Estée Lauder has delivered tangible proof points in its turnaround: fiscal Q4 revenue growth, a sharp EPS beat, $1.2B of cost savings realized and a stronger margin guide. The market has rerated some optimism into the shares, but underlying cash flow and online strength give a credible path for additional upside. This trade idea targets measured ap…
NextPower offers attractive asymmetric upside over the next 45 trading days driven by project maturation, improving utility offtake dynamics, and visible near-term catalysts. The trade is a disciplined long: enter at $4.50, target $6.50, stop $3.75. The thesis accepts execution and policy risk and leaves room for the company to prove it can convert…
